Molecular-pathological correlations in lung cancer

Elisabeth Brambilla (Grenoble, France)

Source: International Congress 2016 – PG7 New guidelines for the classification and staging of lung cancer

Session: PG7 New guidelines for the classification and staging of lung cancer
Session type: Postgraduate Course
Number: 60

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Elisabeth Brambilla (Grenoble, France). Molecular-pathological correlations in lung cancer . International Congress 2016 – PG7 New guidelines for the classification and staging of lung cancer

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

Jesica Mazza Stalder - 29.09.2016 20:44
Great Talk Jesica Mazza-Stalder Switzerland

Ziad Rida - 04.09.2016 13:45
SIMPLY EXCELLENT

You must Login to comment this presentation.

Related content which might interest you:

Aerosoltherapy in lung cancer Source: Annual Congress 2008 - Therapy in thoracic oncology Year: 2008
Venothromboembolism in lung cancer Source: Eur Respir J 2007; 30: Suppl. 51, 601s Year: 2007
EUS-NA in lung cancer Source: Annual Congress 2008 - Endoscopic needle techniques Year: 2008
The evaluation of lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 323s Year: 2005
Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy Source: Eur Respir J 2012; 39: 1437-1442 Year: 2012
Fitness before lung resection in lung cancer patients Source: CME Online 2010 Year: 2010
Procalitonin: A prognosis factor in lung cancer and a marker for small-cell lung cancer Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011
Epigenetics and lung cancer Source: Annual Congress 2006 - Epigenetics and respiratory disease Year: 2006
Staging of non-small-cell lung cancer with FDG-PET/CT: Is there a correlation of morphologic tumor characteristics and metabolic activity? Source: Annual Congress 2012 - Functional imaging in pulmonary oncology and COPD. Radiation dose in chest CT: survey and real life Year: 2012
The relationship between hemoptysis and the features of tumors in primary lung cancer Source: Annual Congress 2007 - Therapy of thoracic malignancies Year: 2007
Missed lung cancer on chest radiography – does it affect the outcome? Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques Year: 2007
Contribution of tumor markers to pretreatment staging of operable lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 360s Year: 2003
Does the lung function affect the survival time in patients with resected non-small cell lung cancer? Source: Annual Congress 2007 - Lung function parameters before and after thoracic surgery Year: 2007
Detecting extrathoracic metastases in patients with non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 41s Year: 2006
A modified ILD-GAP index for patients with non-small cell lung cancer and interstitial lung disease Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018
Staging of lung cancer Source: Eur Respir Mon; 2009: 44: 150–168 Year: 2009
Breast metastasis in association with non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 538s Year: 2005
Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009
Lung cancer Source: Respipedia Article Year: 2018
The burden of emphysema on lung cancer prognosis Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020